Detalhe da pesquisa
1.
A novel fibroblast activation inhibitor attenuates left ventricular remodeling and preserves cardiac function in heart failure.
Am J Physiol Heart Circ Physiol
; 315(3): H563-H570, 2018 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29949382
2.
Pomalidomide reverses γ-globin silencing through the transcriptional reprogramming of adult hematopoietic progenitors.
Blood
; 127(11): 1481-92, 2016 Mar 17.
Artigo
Inglês
| MEDLINE | ID: mdl-26679864
3.
Nutraceutical augmentation of circulating endothelial progenitor cells and hematopoietic stem cells in human subjects.
J Transl Med
; 8: 34, 2010 Apr 08.
Artigo
Inglês
| MEDLINE | ID: mdl-20377846
4.
The novel protein homeostatic modulator BTX306 is active in myeloma and overcomes bortezomib and lenalidomide resistance.
J Mol Med (Berl)
; 98(8): 1161-1173, 2020 08.
Artigo
Inglês
| MEDLINE | ID: mdl-32632752
5.
Circulating endothelial progenitor cells: a new approach to anti-aging medicine?
J Transl Med
; 7: 106, 2009 Dec 15.
Artigo
Inglês
| MEDLINE | ID: mdl-20003528
6.
Lenalidomide and CC-4047 inhibit the proliferation of malignant B cells while expanding normal CD34+ progenitor cells.
Cancer Res
; 67(2): 746-55, 2007 Jan 15.
Artigo
Inglês
| MEDLINE | ID: mdl-17234786
7.
Modulation of cellular differentiation and cell fate for cancer therapy.
Curr Opin Investig Drugs
; 5(12): 1268-73, 2004 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-15648947
8.
Pomalidomide and lenalidomide induce p21 WAF-1 expression in both lymphoma and multiple myeloma through a LSD1-mediated epigenetic mechanism.
Cancer Res
; 69(18): 7347-56, 2009 Sep 15.
Artigo
Inglês
| MEDLINE | ID: mdl-19738071